Ad
related to: does valsartan affect the liver naturally and safely fastGoodRx helps people pay for Rx they otherwise couldn't afford. - Patch
Search results
Results from the WOW.Com Content Network
Valsartan, sold under the brand name Diovan among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease. [8] It belongs to a class of medications referred to as angiotensin II receptor blockers (ARBs).
All of the ARBs, except for valsartan and olmesartan, are metabolized in some way by the cytochrome P450 (CYP) enzyme 2C9, that is found in the human liver. CYP2C9 is for example responsible for the metabolizing of losartan to EXP 3174 and the slow metabolizing of valsartan and candesartan to their inactive metabolites.
Hepatotoxicity (from hepatic toxicity) implies chemical-driven liver damage. Drug-induced liver injury (DILI) is a cause of acute and chronic liver disease caused specifically by medications and the most common reason for a drug to be withdrawn from the market after approval.
Liver regeneration is the process by which the liver is able to replace damaged or lost liver tissue. The liver is the only visceral organ with the capacity to regenerate. [ 1 ] [ 2 ] The liver can regenerate after partial hepatectomy or injury due to hepatotoxic agents such as certain medications, toxins, or chemicals. [ 3 ]
Creatine could help you bulk up fast, but it might also wreck your kidneys, destroy your liver, and bloat you beyond recognition in the process. ... destroy your liver, and bloat you beyond ...
The choice between the drugs is to a large degree determined by the characteristics of the patient being prescribed for, the drugs' side effects, and cost. Most drugs have other uses; sometimes the presence of other symptoms can warrant the use of one particular antihypertensive. Examples include: Age can affect the choice of medications.
Donald Trump has made bold claims about his plans for when he takes office next month, from drastic action at the border to ending birthright citizenship and pardoning January 6 insurrectionists.
Mark Cuban, CEO of Cost Plus Drugs, told BI that AI's impact on a company's workforce will be determined by how well the technology is implemented.